Public Reporting

Identification of ACO participant(s)

  • Crayton Ciborowski, MD
  • Cross Roads Health Center, PLLC
  • Jason N. Peet, MD, PA
  • Wagner & Wagner, PA
  • Family Practice Associates, PA
  • Franklin Clinic, LP
  • Jorge Diaz, MD
  • South Austin Family Practice Clinic, LLP
  • The Vaz Clinic, PA
  • Wagner Medical Clinic, LLP

*No participants are involved in a joint venture between ACO professionals and hospitals

Del Norte ACO Address and Location

Del Norte ACO, LLC

El Paso, TX

ACO Primary Contact:

Identification of the Members of the ACO Governing Body

    • O. Martin Franklin, DO, Co-President – Franklin Clinic, LP
    • Tim Wagner, MD-Medical Director – Wagner & Wagner, PA
    • Marshall Bishop, MD, Treasurer/ Co-Compliance Officer – Wagner Medical Clinic, LLP
    • John D. Davis, MD, Co-Treasurer – Family Practice Associates, PA
    • David R. Sprouse, MD, Secretary/Compliance Officer – Family Practice Associates, PA
    • Garth O. Vaz, MD, Co-President – The Vaz Clinic, PA
    • Jorge Duchicela, MD, – Youens, Duchicela & Associates, PA
    • David Gumper Medicare Co-Rep
    • Dennis Glenewinkel, MBA Medicare Co-Rep
    • Kevin Spencer, MD – South Austin Family Practice Clinic, LLP
    • Gurneet Kohli, MD – South Austin Family Practice Clinic, LLP
    • David Gabriel, MD – South Austin Family Practice Clinic, LLP

Identification of the Types of ACO Participants or Combinations of Participants that Formed the ACO:

Alliance ACO LLC is a Texas, Limited Liability Company comprised of networks of individual practices of ACO professionals.

Amount of Shared Savings/Losses

Performance Year 1 2016: $0 Savings

Performance Year 2 2017: $3,269,673.00 Savings

How Shared Savings are distributed

Reinvestment in the ACO Infrastructure – 75%

Includes rewarding ACO providers and suppliers, as well as development of complex case management, care coordination, analytics, redesigning care processes, and physician education.

Rewarding Quality and Cost-efficient Care of the ACO Participants – 25%

Used to reward physician quality outcomes, beneficiary satisfaction, and financial efficiency in the management of care.

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.

Quality Performance Results

Measure Number Performance Measure 2016 Reporting Period 2017 Reporting Period 2018 Reporting Period
ACO Performance Rate Mean Performance Rate for all ACOs ACO Performance Rate Mean Performance Rate for all ACOs ACO Performance Rate Mean Performance Rate for all ACOs
ACO #1 Getting Timely Care, Appointments, and Information 80.64% 80.51% 80.57% 80.60% Current Year Current Year
ACO#2 How Well Your Doctors Communicate  92.66%  93.01% 92.49% 93.13% Current Year Current Year
ACO #3 Patients’ Rating of Doctor  91.93%  92.25% 92.35% 92.31% Current Year Current Year
ACO #4 Access to Specialists  86.91%  83.49% 85.12% 83.32% Current Year Current Year
ACO #5 Health Promotion and Education  56.53%  60.32% 61.58% 62.30% Current Year Current Year
ACO #6 Shared Decision Making  77.04%  75.40% 77.23% 75.85% Current Year Current Year
ACO #7 Health Status/Functional Status  70.53%  72.30% 72.72% 73.05% Current Year Current Year
ACO #8 Risk Standardized, All Condition Readmissions  14.48%  14.70% 14.86% 15.1% Current Year Current Year
ACO #9 ASC Admissions: COPD or Asthma in Older Adults  9.22%  9.27% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #10 ASC Admission: Heart Failure  11.30%  14.53% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment  35.71%  75.15% 100% 82.72% Current Year Current Year
ACO #12 Medication Reconciliation  N/A   N/A 92.04% 75.32% Current Year Current Year
ACO #13 Falls: Screening for Fall Risk  36.69%  64.04% 66.86% 74.38% Current Year Current Year
ACO #14 Influenza Immunization  70.56%  68.32% 74.72% 72.52% Current Year Current Year
ACO #15 Pneumococcal Vaccination  70.16%  69.21% 85.23% 72.92% Current Year Current Year
ACO #16 Adult Weight Screening and Follow-up  70.97%  74.45% 86.33% 70.69% Current Year Current Year
ACO #17 Tobacco Use Assessment and Cessation Intervention  89.11%  90.98% 95.95% 90.48% Current Year Current Year
ACO #18 Depression Screening 38.31%  53.63% 68.68% 61.98% Current Year Current Year
ACO #19 Colorectal Cancer Screening  58.47%  61.52% 77.50% 64.58% Current Year Current Year
ACO #20 Mammography Screening  64.61%  67.61% 72.73% 70.05% Current Year Current Year
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years  85.48%  76.79% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) ACO #24 Blood Pressure (BP) <140/90   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL)   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #24 Blood Pressure (BP) <140/90   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #25 Tobacco Non Use   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #26 Aspirin Use   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)  17.74%  18.24% 11.22% 16.74% Current Year Current Year
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90  69.40%  70.69% 72.69% 71.47% Current Year Current Year
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic  88.71%  85.05% 85.16% 86.86% Current Year Current Year
ACO #31 Beta-Blocker Therapy for LVSD  93.83%  88.67% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #32 Drug Therapy for Lowering LDL Cholesterol   N/A   N/A Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD  78.07%  79.67% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #34 CAHPS: Stewardship of Patient Resources  28.44%  26.97% 29.59% 25.68% Current Year Current Year
ACO #35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)  19.41%  18.17% 18.52% 18.46% Current Year Current Year
ACO #36 All-Cause Unplanned Admissions for Patients with Diabetes  52.49%  53.20% 58.15% 53.95% Current Year Current Year
ACO #37 All-Cause Unplanned Admissions for Patients with Heart Failure  75.88%  75.23% 78.29% 79.16% Current Year Current Year
ACO #38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions  60.83%  59.81% 63.52% 61.74% Current Year Current Year
ACO #39 Documentation of Current Medications in the Medical Record  93.75%  87.54% Final Results Not Calculated Final Results Not Calculated Current Year Current Year
ACO #40 Depression Remission at Twelve Months  0%  6.40% 6.25% 7.93% Current Year Current Year
ACO #41 Diabetes: Eye Exam  26.61%  44.94% 51.60% 50.37% Current Year Current Year
ACO #42 Statin therapy for the Prevention and Treatment of Cardiovascular Disease  77.24%  77.72% 78.24% 79.89% Current Year Current Year
ACO #43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) – – 1.91% 1.93% Current Year Current Year
ACO #44 Imaging Studies for Low Back Pain  – – 65.22% 67.32% Current Year Current Year